Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Clinical trial NCT00566852 · COMPLETED

Trial details

NCT number: NCT00566852
Sponsor: Radiation Therapy Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cognitive/Functional Effects Metastatic Cancer Neurotoxicity Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2008-03-01
Primary completion: 2011-04-01
Enrollment: 554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.